In Vivo Radioligand Therapy Scientist – Preclinical

C028 (FCRS = CH028) Novartis Pharma AG; Basel; Presencial; CHF 76.000 - 142.000; Tempo integral

Benefícios oferecidos por esta vaga

Insurance plans

Retirement plans

Wellbeing resources

Global recognition programs

Parental leave

Resumo da vaga

Novartis Pharma AG in Basel, Switzerland, seeks a Research Scientist to advance preclinical radioligand therapy. You will develop oncology models, evaluate novel radioligand therapies, and generate insights to support the Oncology portfolio. Collaboration across global teams and experience with rodent work and imaging are essential.

Responsibilities include biodistribution, pharmacology-informed decisions, and integration of imaging data to translate science into potential therapies for patients.

Qualificações

• Bachelor's or master's degree in a related biomedical field.
• Hands-on experience with rodent handling and in vivo oncology models.
• Practical experience working safely with open radioactive sources.
• Advanced written and spoken English communication.

Responsabilidades

• Develop and characterize in vivo oncology models to support preclinical radioligand therapy research.
• Conduct efficacy studies evaluating radioligand therapies across oncology programs.
• Perform biodistribution studies and metabolite analyses for pharmacology decisions.
• Conduct small-animal PET, SPECT, and CT imaging studies.
• Support in vitro and ex vivo activities (cell culture, flow cytometry, IHC, PCR, Western blot).

Conhecimentos

Analytical Thinking

Data Analysis

Collaboration

Scientific Communication

Formação

Bachelor's or Master's degree in Cell Biology, Medical Physics, Bioengineering, Biotechnology, Pharmacology, or related field

Ferramentas

PET imaging

SPECT imaging

CT imaging

Imaging analysis software

Rodent handling

Descrição da vaga

Novartis Pharma AG in Basel, Switzerland, seeks a Research Scientist to advance preclinical radioligand therapy. You will develop oncology models, evaluate novel radioligand therapies, and generate insights to support the Oncology portfolio. Collaboration across global teams and experience with rodent work and imaging are essential.

Responsibilities include biodistribution, pharmacology-informed decisions, and integration of imaging data to translate science into potential therapies for patients.